Evidence map›Paper›PMID 41230544›Full record

ArticleFrontiers in human neuroscience2025

Hypertrophic olivary degeneration secondary to brain abscess: a case report and literature review.

Shihan Tian, Biqiu Tang, Kai Zhang, Xiaohe Tian, Na Hu

Abstract readCase Reports
In one paragraph

Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shihan TianDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Biqiu TangDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Kai ZhangDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.
Xiaohe TianDepartment of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Na HuDepartment of Radiology, West China Hospital of Sichuan University, Chengdu, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Hypertrophic olivary degeneration (HOD) is a rare transsynaptic neurodegenerative disorder arising from disruption of the Guillain-Mollaret triangle (GMT), a neural circuit critical for motor coordination. Classical clinical presentation includes palatal tremor. While cerebrovascular etiology dominates reported cases, HOD secondary to intracranial infections remains poorly characterized, posing diagnostic challenges. Case presentation: A 72-year-old man with diabetes and hypertension presented with a 7-day history of fever, headache, and vomiting. Initial neuroimaging revealed right cerebellar hematoma with multiple brain abscesses. Antibacterial treatment achieved symptomatic improvement, but follow-up was lost. Seven months later, readmission occurred due to memory decline and personality changes. Magnetic resonance imaging (MRI) showed T Conclusion: This case documents a rare case of HOD following bacterial brain abscess, presenting with atypical clinical features. It expands the etiological spectrum of HOD and underscores the need for heightened clinical suspicion in post-infectious neurological deterioration. Multimodal MRI facilitates early diagnosis and timely intervention, highlighting its critical role in managing this underrecognized entity.

Indexed as

brain abscesscase reportdiffusion tensor imaginghypertrophic olivary degenerationmagnetic resonance imaging

Identifiers

PMID41230544
PMCPMC12602417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.